Signet Therapeutics ("Signet"), a clinical-stage biotech company leveraging organoids and AI to develop first-in-class cancer therapies, today announced that the first patient has been dosed in the ...
At the exhibition, Yamaha Motor will showcase the CELL HANDLERtm 2 in action. Additionally, the Dutch-based biotechnology companies HUB Organoids and MIMETAS will present poster sessions on their ...
Ten per cent of Canadians live in communities susceptible to workforce disruption in the coming years because of global and domestic efforts to reduce greenhouse-gas emissions, according to a major ...